Top Institutions in Gene Therapy and Genome Editing
Leading institutions employ advanced next-generation sequencing techniques, comprehensive bioinformatics pipelines, and rigorous clinical trial designs to evaluate off-target effects, genome integrity, and therapeutic efficacy of genome editing and CAR-T therapies. They also integrate translational research with regulatory science to align with FDA guidance on genome editing safety.
-
#1
National Institutes of Health (NIH) - National Heart, Lung, and Blood Institute (NHLBI)
Bethesda, MD
The NIH NHLBI leads in genome editing research with extensive infrastructure for gene therapy clinical trials, including pioneering work in CAR-T therapies and genome editing safety assessments aligned with FDA standards.
Key Differentiators
- Gene Therapy
- Genome Editing
- Hematology
- Immunotherapy
-
#2
University of Pennsylvania - Abramson Cancer Center
Philadelphia, PA
Home to the first FDA-approved CAR-T therapies, Penn has a robust translational research program integrating genome editing technologies with clinical applications in lymphoma and leukemia.
Key Differentiators
- CAR-T Therapy
- Gene Therapy
- Hematologic Malignancies
-
#3
Memorial Sloan Kettering Cancer Center
New York, NY
MSKCC integrates cutting-edge genome editing research with clinical trials in hematologic cancers, emphasizing safety and efficacy of CAR-T and gene-edited therapies.
Key Differentiators
- Hematology
- Gene Therapy
- Immunotherapy
-
#4
Stanford University School of Medicine
Stanford, CA
Stanford is a leader in genome editing technology development and translational research, with strong programs in CRISPR safety assessment and CAR-T therapy innovation.
Key Differentiators
- Genome Editing
- Gene Therapy
- Immuno-oncology
-
#5
Fred Hutchinson Cancer Center
Seattle, WA
Fred Hutch has a long-standing history in hematologic malignancies and cell therapy, with significant contributions to CAR-T therapy clinical development and genome editing safety research.
Key Differentiators
- Hematology
- Gene Therapy
- Cell Therapy
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
